Suppr超能文献

340B 计划对低收入患者的医疗质量的影响。

The impacts of the 340B Program on health care quality for low-income patients.

机构信息

Department of Population Health, New York University Grossman School of Medicine, New York City, New York, USA.

New York University Wagner Graduate School of Public Service, New York City, New York, USA.

出版信息

Health Serv Res. 2023 Oct;58(5):1089-1097. doi: 10.1111/1475-6773.14204. Epub 2023 Jul 20.

Abstract

OBJECTIVE

To assess the effects of hospital 340B eligibility on quality of inpatient care provided to Medicaid and uninsured patients and for all patients.

DATA

Agency for Health Care Research and Quality's Healthcare Cost and Utilization Project State Inpatient Data, Hospital Cost Reporting Information System Data, Office of Pharmacy Affairs Information System Data, and American Hospital Association Annual Survey.

DESIGN

Regression discontinuity design comparing hospitals just above the DSH percentage program eligibility threshold to those just below. Quality measures include all-cause mortality and 30-day readmission rates as well as condition-specific measures.

DATA EXTRACTION

Inpatient data from general acute care hospitals from 2008 to 2014 in 15 states. Data linked on hospital 340B eligibility and participation.

PRINCIPAL FINDINGS

We did not find discontinuities in inpatient care quality across the Program eligibility threshold for Medicaid and uninsured patients; specifically, on all-cause mortality (beta = -0.04 percentage points, 95% CI: -0.16, 0.08), 30-day readmission rates (beta = -0.16 percentage points, 95% CI: -0.81, 0.5), or other measures. Among insured and non-Medicaid patients, we found discontinuities for acute myocardial infarction (beta = -0.87 percentage points, 95% CI: -1.55, -0.2) and postoperative sepsis (beta = -0.15 percentage points, 95% CI: -0.23, -0.07) mortality.

CONCLUSIONS

340B Program participation has not demonstrated improved quality of inpatient care among Medicaid or uninsured patients.

摘要

目的

评估医院 340B 资格对向医疗补助和无保险患者以及所有患者提供的住院治疗质量的影响。

数据

医疗保健成本和利用项目州住院数据、医院成本报告信息系统数据、药房事务信息系统数据和美国医院协会年度调查的美国卫生保健研究与质量局。

设计

比较刚好超过 DSH 百分比计划资格门槛的医院和刚好低于门槛的医院的回归不连续性设计。质量衡量标准包括全因死亡率和 30 天再入院率以及特定疾病的衡量标准。

数据提取

来自 2008 年至 2014 年 15 个州的普通急症护理医院的住院数据。数据与医院 340B 资格和参与情况相关联。

主要发现

我们没有发现 Medicaid 和无保险患者计划资格门槛的住院治疗质量存在不连续性;具体来说,在全因死亡率(β=-0.04 个百分点,95%CI:-0.16,0.08)、30 天再入院率(β=-0.16 个百分点,95%CI:-0.81,0.5)或其他衡量标准方面。在有保险和非 Medicaid 患者中,我们发现急性心肌梗死(β=-0.87 个百分点,95%CI:-1.55,-0.2)和术后败血症(β=-0.15 个百分点,95%CI:-0.23,-0.07)死亡率存在不连续性。

结论

340B 计划的参与并未证明在 Medicaid 或无保险患者中改善了住院治疗质量。

相似文献

1
The impacts of the 340B Program on health care quality for low-income patients.
Health Serv Res. 2023 Oct;58(5):1089-1097. doi: 10.1111/1475-6773.14204. Epub 2023 Jul 20.
2
US Hospital Service Availability and New 340B Program Participation.
JAMA Health Forum. 2024 May 3;5(5):e240833. doi: 10.1001/jamahealthforum.2024.0833.
3
Relationship between initiation of 340B participation and hospital safety-net engagement.
Health Serv Res. 2020 Apr;55(2):157-169. doi: 10.1111/1475-6773.13278.
4
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
BMC Res Notes. 2021 Jun 3;14(1):228. doi: 10.1186/s13104-021-05642-4.
5
Consequences of the 340B Drug Pricing Program.
N Engl J Med. 2018 Feb 8;378(6):539-548. doi: 10.1056/NEJMsa1706475. Epub 2018 Jan 24.
6
340B Participation and Safety Net Engagement Among Federally Qualified Health Centers.
JAMA Health Forum. 2024 Oct 4;5(10):e243360. doi: 10.1001/jamahealthforum.2024.3360.
7
Financial Loss for Inpatient Care of Medicaid-Insured Children.
JAMA Pediatr. 2016 Nov 1;170(11):1055-1062. doi: 10.1001/jamapediatrics.2016.1639.
9
Association Between the 2014 Medicaid Expansion and US Hospital Finances.
JAMA. 2016 Oct 11;316(14):1475-1483. doi: 10.1001/jama.2016.14765.
10
Did budget cuts in Medicaid disproportionate share hospital payment affect hospital quality of care?
Med Care. 2014 May;52(5):415-21. doi: 10.1097/MLR.0000000000000114.

引用本文的文献

1
The Association of 340B Program Drug Margins with Covered Entity Characteristics.
Inquiry. 2025 Jan-Dec;62:469580251324051. doi: 10.1177/00469580251324051. Epub 2025 Mar 23.
2
340B Participation and Safety Net Engagement Among Federally Qualified Health Centers.
JAMA Health Forum. 2024 Oct 4;5(10):e243360. doi: 10.1001/jamahealthforum.2024.3360.

本文引用的文献

1
340B Drug Pricing Program and hospital provision of uncompensated care.
Am J Manag Care. 2021 Oct;27(10):432-437. doi: 10.37765/ajmc.2021.88761.
2
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
BMC Res Notes. 2021 Jun 3;14(1):228. doi: 10.1186/s13104-021-05642-4.
3
Relationship between initiation of 340B participation and hospital safety-net engagement.
Health Serv Res. 2020 Apr;55(2):157-169. doi: 10.1111/1475-6773.13278.
4
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.
JAMA Netw Open. 2019 Oct 2;2(10):e1914141. doi: 10.1001/jamanetworkopen.2019.14141.
5
Diversity of Participants in the 340B Drug Pricing Program for US Hospitals.
JAMA Intern Med. 2018 Aug 1;178(8):1124-1127. doi: 10.1001/jamainternmed.2018.2015.
6
Consequences of the 340B Drug Pricing Program.
N Engl J Med. 2018 Feb 8;378(6):539-548. doi: 10.1056/NEJMsa1706475. Epub 2018 Jan 24.
7
Impact of the 340B Drug Pricing Program on Cancer Care Site and Spending in Medicare.
Health Serv Res. 2018 Oct;53(5):3528-3548. doi: 10.1111/1475-6773.12823. Epub 2018 Jan 22.
8
Racial disparities in comorbidity and severe maternal morbidity/mortality in the United States: an analysis of temporal trends.
Acta Obstet Gynecol Scand. 2018 Jan;97(1):89-96. doi: 10.1111/aogs.13245. Epub 2017 Nov 1.
10
The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.
Health Aff (Millwood). 2014 Oct;33(10):1786-92. doi: 10.1377/hlthaff.2014.0540.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验